Jennifer L. Taubert - 22 Nov 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, WW Chair, Pharmaceuticals
Signature
Raavi K. Deol, as attorney-in-fact for Jennifer L. Taubert
Issuer symbol
JNJ
Transactions as of
22 Nov 2022
Net transactions value
-$8,018,407
Form type
4
Filing time
23 Nov 2022, 15:44:21 UTC
Previous filing
07 Oct 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $5,579,994 +76,923 +61% $72.54 203,379 22 Nov 2022 Direct
transaction JNJ Common Stock Sale $13,598,402 -76,923 -38% $176.78 126,456 22 Nov 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -76,923 -100% $0.000000* 0 22 Nov 2022 Common Stock 76,923 $72.54 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $176.525 to $177.190. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.